May 27, 2025

Cost Pressures in Medical Device Manufacturing: Strategies for OEMs

close up of manufacturing of an electronic medical device being assembled in a production plant-1

Navigating the intricate landscape of medical device manufacturing is no small feat, especially when cost pressures loom large over OEMs.

Escalating raw material prices, tighter reimbursement rates from Medicare and Medicaid, and new tariffs on critical components are squeezing margins across the medical device industry. If you’re an OEM, every fluctuation in resin or electronics pricing, every unexpected supply chain disruption, and every additional Food and Drug Administration (FDA) compliance requirement can turn forecasted profit into unplanned expense.

Staying competitive in today’s medical devices market demands a proactive approach to cost control. Device manufacturers that quickly identify inefficiencies, fortify supply chains, and benchmark production costs against best-in-class contract manufacturing partners are better positioned to protect their bottom line. By addressing cost pressures head-on, you safeguard capital for innovation, maintain price flexibility with healthcare providers, and ensure that your devices reach patients without compromising safety or regulatory compliance.

Understanding the Key Cost Drivers in Medical Device Manufacturing

A clear view of where costs originate is the first step toward controlling them. Below is a concise breakdown of the factors most responsible for escalating production costs in the medical device industry:

  • Raw materials and components: Specialty plastics, medical-grade metals, and electronic subassemblies can account for 20–50 % of total production costs, with price volatility amplified by commodity swings and tariffs on imported parts.
  • Regulatory compliance: Maintaining ISO 13485 certification, performing process validations, and preparing Design History Files (DHF) and Device History Records (DHR) require dedicated staff, audits, and recurring fees to bodies such as the FDA and Notified Bodies.
  • Quality assurance and validation: Biocompatibility testing, reliability studies, and ongoing Corrective and Preventive Action (CAPA) programs add labor and capital expenses.
  • Tooling, fixtures, and automation: Up-front investments in high-precision molds and automated assembly equipment drive significant capital outlay, especially for complex Class II devices.
  • Labor and skill mix: Highly skilled technicians and engineers are essential for advanced medical technology, pushing labor rates well above general electronics manufacturing.
  • Production volume and yield: Low or variable volumes limit economies of scale, while scrap, rework, or low first-pass yields quickly inflate unit costs.
  • Logistics and distribution: Cold-chain requirements, specialized packaging, and rising freight rates elevate landed costs, especially when devices ship globally.

With so many variables at play, OEMs need structured, data-driven strategies to offset these pressures. The next section explores proven tactics—ranging from outsourcing to contract manufacturers to advanced supply chain optimization, that help medical device manufacturers regain cost control without sacrificing quality or compliance.

 

Strategies OEMs Can Implement to Address Cost Pressures

Outsourcing portions—or the entirety—of production to a qualified contract manufacturing organization (CMO) remains one of the most effective levers for lowering production costs. CMOs dedicated to medical devices spread regulatory compliance costs across multiple programs, leverage economies of scale on raw materials components, and maintain specialized labor pools that smaller OEM facilities struggle to match. By shifting capital-intensive processes such as injection molding, SMT placement, or sterile packaging to a CMO, you avoid large equipment purchases, reduce overhead, and convert fixed costs into variable expenses that scale with demand.

Beyond outsourcing, medical device manufacturers can deploy a multi-pronged strategy to further reduce costs and protect margins:

  • Supply chain optimization: Consolidate vendors, implement dual-sourcing for high-risk parts, and position raw materials closer to assembly sites to reduce lead times, mitigate tariff exposure, and cut freight spend.
  • SKU rationalization: Analyze product catalogs for low-volume or duplicate models, eliminating variants that drive excess inventory, tooling, and qualification costs without meaningful revenue contribution.
  • Value-based pricing: Align device pricing with demonstrated clinical or economic outcomes, strengthening negotiations with healthcare providers and cushioning margin impact from rising production costs.
  • Design-for-manufacture and assembly (DFMA): Engage manufacturing engineers early to simplify part geometry, minimize fasteners, and select cost-effective materials, reducing labor minutes and scrap rates.
  • Lean manufacturing and automation: Implement standardized work cells, error-proofing, and targeted robotics to improve first-pass yield and lower per-unit labor, especially valuable in regions facing wage inflation.
  • Currency and commodity hedging: Lock in exchange rates for overseas purchases and secure long-term contracts on critical alloys or resins to protect against volatility driven by geopolitical events.
  • Strategic inventory buffering: Use data analytics to balance carrying costs against the risk of line-down events from supply chain disruptions, ensuring uninterrupted delivery to hospitals and Medicare-funded facilities.

While each tactic delivers incremental savings, the most significant cost reductions occur when multiple levers operate within a cohesive manufacturing model. That’s where an experienced and versatile contract manufacturing partner can make the difference. In the next section, we’ll examine how Sanbor Medical’s unique manufacturing models combine these strategies to help OEMs capture 20–25 % cost savings without sacrificing regulatory compliance or product quality.

 

How Sanbor Medical’s Manufacturing Models Address Cost Challenges

Sanbor Medical is committed to helping OEMs navigate the cost challenges inherent in medical device manufacturing. Our comprehensive suite of services includes contract manufacturing, supply chain management, and quality assurance, all designed to optimize costs without compromising quality.

We leverage our extensive industry experience and advanced manufacturing technologies to deliver cost-effective solutions. By partnering with Sanbor Medical, OEMs can benefit from our economies of scale, specialized expertise, and robust supplier networks. Our focus on lean manufacturing principles and continuous improvement ensures that we provide high-quality products efficiently and cost-effectively, helping our clients achieve their financial and operational goals.

 

Partnering for Success in Medical Device Manufacturing

Persistent cost pressures—from volatile raw material prices to shifting tariffs—will continue to test medical device manufacturers. Proactively managing these forces is no longer optional; it’s a prerequisite for sustaining innovation, securing reimbursement, and maintaining a competitive edge in a market increasingly driven by value and efficiency.

When you collaborate with a contract manufacturer that offers both hybrid flexibility and vertical integration, you gain the tools to cut production costs, stabilize your supply chain, and keep every product fully compliant with FDA and international regulations. Contact Sanbor Medical to learn how their manufacturing solutions can help reduce costs and improve efficiency.

Subscribe to email updates

Smarter Manufacturing Starts Here.

Connect with our team to learn how a Sanbor partnership is the future of medical device contract manufacturing.

Connect With Us